
Antimicrobial Peptides Against Antibiotic Resistance: A Key Direction in the Global Anti-Infective Market
As antibiotic resistance continues to worsen worldwide, the pharmaceutical industry is searching for next-generation anti-infective…

As antibiotic resistance continues to worsen worldwide, the pharmaceutical industry is searching for next-generation anti-infective…

On June 22, 2026, China’s National Medical Products Administration (NMPA) officially approved Eli Lilly’s innovative…

Liver cancer is one of the most serious and life-threatening cancers worldwide. According to the…

On June 22, 2026, China’s National Medical Products Administration (NMPA) officially approved Silevimig Injection (Jinsuxi®),…

RNA therapeutics for cardiovascular disease are emerging as a transformative strategy for long-term disease management.…

On June 22, 2026, China’s National Medical Products Administration (NMPA) approved Satricabtagene Autoleucel (Kailimei®), developed…

Cancer treatment is often a long and uncertain journey. Global pharmaceutical distributor DengYueMed has organized…

On June 22, 2026, NMPA officially approved Biokin Pharmaceutical’s independently developed Class 1 innovative drug,…

Over the past two decades, the China API industry has evolved into a foundational pillar…

In the global healthcare system, generic drugs have become an important way to reduce treatment…